Global Patient Support Programs Market Analysis by Insights10 - HTML preview

A sample report on

Global Patient

Support Programs

Market Analysis

Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2021 – 2030F) www.insights10.com

This report presents a strategic analysis of the Global Patient Support Program market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, characteristics, main players, trends and insights, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Global Patient Support Program market, and offers unmatched value, accuracy, and expert insights

• Introduction

• Market Overview

• Growth Drivers & Restraints

Table of

• Market Segmentation

• Major Market Share

Contents

• Competitive Landscape

• Pharma Companies Sponsored PSPs

• Healthcare Policies & Regulatory Framework

• Factors Driving Future Growth

• Conclusion

Table of Contents

1. Introduction…………………………………………………………………………………….………………………………..…………..7

1.1 Need for Patient Services

1.2 Patient support programs: What do they offer?

1.3 Various Patient Services

1.3.1 Caregiver Access

1.3.2 Healthcare Financing

1.3.3 Self Care/Compliance

1.4 Strong Desire for Support Services from Pharma Manufacturers

2. Global Patient Support Program Market Overview………………..……..…………………………………...................................15

2.1 Market size and forecast

3. Market Growth Drivers and Restraints….………………………………………………………………….…………….…………….17

3.1 Market Growth Drivers

3.1.1 Greater focus on Value and Outcomes

3.1.2 Growth in availability of Health Data

3.1.3 Shift from Reactive to Proactive Consumer 3.1.4 Rise of Personalized Medicine

3.2 Market Restraints

4

A Sample Report on Global Patient Support Program Market I Confidential

Table of Contents (continued)

3.2.1 Siloed and Uncoordinated communications 3.2.2 Lack of Data Governance

3.2.3 Challenge of Program Management

3.2.4 Cost Ambiguity

4. Market Segmentation……………………………………………………………….…………………..…………………..………….….24

4.1 By Caregiver Access

4.2 By Healthcare Financing

5. Major Products Market Share………………………..…………………………………………………………………..…………....…28

5.1 Market Analysis, Insights and Forecast - By Revenue

6. Competitive Landscape……………………………………………………..……………………...…………..…................................30

6.1 Major companies for global market

7. Pharma companies sponsored PSP Programs…………………………………………………………...………………..…….......32

7.1 Connect360 (AstraZeneca)

7.2 Amgen Assist 360 (Amgen)

7.3 BMS Access Support (Bristol Myers Squibb) 7.4 Lilly Cares (Eli Lilly)

5

A Sample Report on Global Patient Support Program Market I Confidential

Table of Contents (continued)

8. Healthcare Policies and Regulatory Landscape…………………………………………………….……………………..………....37

8.1 Regulatory framework of global patient support program market

9. Factors Driving Future Growth………………………………………………………………………………………………..………....39

9.1 Recent developments in patient support program

10. Strategic Recommendation……………………..…………..………………………………….……………………………………….41

6

A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis 1. Introduction

1.1 Need for Patient Services

People experience various difficulties around starting their medications and continuing to take them as prescribed, leading to suboptimal behaviors that result in non-adherence

▪ Medication adherence is one of healthcare’s greatest and most costly challenges

▪ Non-adherence is estimated to cause approximately xx deaths in the US annually, costing the US health care system up to $xx Bn/ year

▪ It is a nuanced and multi-factorial challenge, and patients’ needs while on treatment are highly differentiated More serious the health condition of a patient, the more Many patients want to receive support via phone. However, various digital channels like 8

A Sample Report on Global Patient Support Program Market I Confidential

1.2 Patient Support Programs: What do they offer?

Patient Support Programs (PSPs)

Patient Access Programs

Patient Adherence Programs

Convenience Programs

Financial

Named Patient

Patient Education

Other Support

Assistance

Loyalty Programs

Programs (NPP)

Programs

Programs

Programs

9

A Sample Report on Global Patient Support Program Market I Confidential

1.3 Various Patient Services

Caregiver Access

Healthcare Financing

Self Care/ Compliance

Virtual Care/

Benefit Coverage

Patient Education/

Telehealth

(BI/PA/Appeal)

discovery

Remote Monitoring

Medication delivery /

Co-pay assistance

support

10

A Sample Report on Global Patient Support Program Market I Confidential

1.3.1 Caregiver Access – (1/2)

Virtual Care/

Platform enabling remote delivery of healthcare services Telehealth

Companies in the space

Remote patient monitoring enables monitoring of patients outside conventional clinical settings Remote Monitoring

thereby increasing access to care and reducing healthcare delivery costs Companies in the space

Companies in the space

11

A Sample Report on Global Patient Support Program Market I Confidential

1.3.2 Healthcare Financing – (1/3)

Electronic Prior

ePA is the electronic transmission of information between the prescriber, and payer to determine Authorization (ePA)

whether or not the PA is granted

Companies in the space

Real Time Benefits

Providers need visibility into patient benefits to determine patient’s needs. RTBV technologies Verification

integrate this information into provider workflows to improve care planning Companies in the space

Companies in the space

12

A Sample Report on Global Patient Support Program Market I Confidential

1.3.3 Self Care / Compliance

Tools and platform that enables healthcare professionals and physicians to impart information and Patient Education

knowledge to patients thereby altering their health behaviors and improving health outcomes Companies in the space

Services enabling timely delivery of prescriptions at patients doorstep/ convenient location to Medication Delivery

drive long term adherence through convenience Companies in the space

Companies in the space

13

A Sample Report on Global Patient Support Program Market I Confidential

1.4 Strong Desire for Support Services from Pharma Manufacturers

Survey of more than 1,000 patients with chronic / complex conditions was conducted to evaluate the patient experience on

therapy: commonly encountered challenges related to access and adherence, support used, preferred, and expectations from

the manufacturer of the medications

xx% of respondents believe that pharma companies xx% respondents needed financial and copay support should offer patient support services

xx% respondents wanted services for frequent xx% of those with complex or chronic conditions say medication reminders

that they would opt in for patient support services xx% people wanted companion to talk to about their xx% of cancer and xx% of lupus patients agreed to medication and emotional concerns while dealing with opting patient support services

disease and treatment

xx% were aware of the patient support services that are xx% said increased communications from a physician currently offered by drug manufacturers, despite its high or nurse would be most beneficial

demand

xx% said calls/visits from a nurse who is an expert in xx% actually reported utilization of pharma-provided the medication the patient is on would be most helpful services

14

A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis 2. Overview

2.1 Market Size and Forecast

Global Patient Support Program Market Size $Bn Key Analysis

Patients believe pharmaceutical companies have a xx% responsibility

Patients are aware of the services that pharmaceutical xx% companies

xx% Pharma companies are raising their investment in 5.1

xx% Healthcare professionals are very aware of Patients believe that pharma companies should be xx% working more closely with

2021

2022F

2023F

2024F

2025F

2026F

2027F

2028F

2029F

2030F

16

A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis 3. Growth Drivers & Restraints

Market growth drivers and restraints

Greater Focus on Value

Growth in Availability of

Shift from Reactive

s

Rise of Personalized

and Outcomes

Health Data

to Proactive Consumer

er

Medicine

iv

Dr

act

t

ke

Imp

Mar

aints

t

str

Ret

Impac

Siloed and Uncoordinated

Lack of Data Governance

ke

Challenge of Program

Cost Ambiguity

communications

Measurement

Mar

18

A Sample Report on Global Patient Support Program Market I Confidential

3.1 Market growth drivers

3.1.1 Greater Focus on Value and Outcomes

▪

Life sciences organizations are under pressure to justify their pricing and to demonstrate that their drugs can improve treatment outcomes

19

A Sample Report on Global Patient Support Program Market I Confidential

3.1 Market growth drivers (continued)

3.1.2 Growth in Availability of Health Data

▪

Sources like electronic medical records, claims and billing information, big data from wearables or social media helps companies understand the quality, efficiency and safety of their treatments 20

A Sample Report on Global Patient Support Program Market I Confidential

3.1 Market growth drivers (continued)

3.1.3 Shift from Reactive to Proactive Consumer

▪

Patients today take a more active role in managing their own health 21

A Sample Report on Global Patient Support Program Market I Confidential

3.1 Market growth drivers (continued)

3.1.4 Rise of Personalized Medicine

▪

With growth of specialty drugs and personalized therapies, demand for individualized treatments is increasing 22

A Sample Report on Global Patient Support Program Market I Confidential

3.2 Market restraints

3.2.1 Siloed and Uncoordinated

3.2.2 Lack of Data Governance

communications

▪

Patient services programs typically are executed

▪

Patient services data is often unstructured and by multiple departments for multiple brands

lacking when it comes to data governance and

utilizing both internal teams and external

stewardship…..

partners leading to…..

3.2.3 Challenge of Program Measurement

3.2.4 Cost Ambiguity

▪

Measuring patient services program

▪

Generally, cost prediction is done at the

effectiveness is often unstructured and lacks aggregate level for multiple programs and in

clear success criteria, manufacturers will

annual buckets, and there is no clear…..

utilize…..

23

A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis 4. Market Segmentation

Global Patient Support Program Market Segmentation Patient Support Program Market Segmentation Caregiver Access

Healthcare Financing

Virtual Care/ Telehealth

Benefit Coverage (BI/PA/Appeal)

Remote Monitoring

Co-pay assistance

Healthcare at Home

Alternative Coverage / PAPs

Patient Transportation

Reimbursement Support

Health Coaching

25

A Sample Report on Global Patient Support Program Market I Confidential

4.1 Market Segmentation: By Caregiver Access Patient Support Program Market Share by Caregiver Access Key Insights

(2021)

▪

Remote patient monitoring enables monitoring of patients outside conventional clinical settings thereby increasing access to care and reducing healthcare delivery costs

▪

Home healthcare is a supportive care provided by medical professionals at patient’s home for the purpose of promoting, maintaining or restoring health or maximizing the level of independence while minimizing the effects of disability and illness

Virtual Care/

Remote

Healthcare at

Patient

Health

Telehealth

Monitoring

Home

Transportation

Coaching

26

A Sample Report on Global Patient Support Program Market I Confidential

4.2 Market Segmentation: By Healthcare Financing Patient Support Program Market Share by Healthcare Financing Key Insights

(2021)

▪

Electronic Prior Authorization (ePA)- it is the electronic transmission of information between the prescriber, and payer to determine whether or not the PA is granted

▪

Reimbursement Support - Services remove barriers to successful payment of claims and provide a resource for patients with coverage-related questions

Benefit Coverage

Co-pay

Alternative

Reimbursement

(BI/PA/Appeal)

Assistance

Coverage / PAPs

Support

27

A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis 5. Major Market Share

5.1 Major Patient Support Program Market Share Key Insights

▪

From the pharmaceutical company’s perspective, PSPs contribute to better patient outcomes overall, and as the industry shifts more toward outcomes-based payment models, enhancing actual patient outcomes will be a crucial success element

▪

A strong patient support program will influence the approval of treatments and market authorizations and will boost patient enrollment

29

A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis 6. Competitive Landscape

6.1 Major players revenue (current and forecast) Major Market Revenue of Patient Support Services Key Insights

Companies ($Bn)

SAMPLE

AstraZeneca

Amgen (Assist

Bristol Myers

Eli Lilly (Lilly

(Access 360)

360)

Squibb (Access

Cares)

Support)

Revenue share used for PSP

Other revenue

31

A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis 7. Pharma companies sponsored PSP Programs

7.1 Connect360 (AstraZeneca)

Respective PSP Overview

Company at a Glance

▪

The AstraZeneca Patient Support Programs help patients Company Name: AstraZeneca

navigate the complexities of reimbursement and provide support during the journey of their treatment

▪

Connect360, AstraZeneca Oncology patient support programs Year of Establishment: 1999

are some of the PSPs going on currently

Headquarter: Cambridge, US

Revenue: $37.4 Bn (2021)

Website: www.astrazeneca.com

33

A Sample Report on Global Patient Support Program Market I Confidential

7.2 Amgen Assist 360 (Amgen)

Respective PSP Overview

Company at a Glance

▪

In 2019, the Amgen Safety Net Foundation provided nearly Company Name: Amgen

$1.5 billion worth of our medicines to qualified uninsured or underinsured patients in the U.S. at no cost -and Early $7

billion of our medicines since 2008

Year of Establishment: 1980

▪

Amgen Assist 360 provides financial support options for any insurance type and referrals to resources for day-to-day living Headquarter: Cambridge, US

Revenue: $26 Bn (2021)

Website: www.amgen.com

34

A Sample Report on Global Patient Support Program Market I Confidential

7.3 BMS Access Support (Bristol Myers Squibb) Respective PSP Overview

Company at a Glance

▪

Bristol Myers Squibb is committed to helping appropriate Company Name: Bristol Myers Squibb

patients get access to our medications by providing access and reimbursement support services`

▪

BMS Access Support® is focused on your patients’ access Year of Establishment: 1887

needs benefits Review, prior authorization, and appeals assistance, easy-to-initiate co-pay assistance process and information on financial support and support from Patient Access Specialists, assigned by region, and local Access and Headquarter: New York, US

Reimbursement Managers

Revenue: $46.4 Bn (2021)

Website: www.bms.com

35

A Sample Report on Global Patient Support Program Market I Confidential

7.4 Lilly Cares (Eli Lilly)

Respective PSP Overview

Company at a Glance

▪

Lilly Cares Foundation, Inc. (Lilly Cares) is a nonprofit Company Name: Eli Lilly

charitable organization that provides prescribed Lilly medications for free for up to 12 months to qualifying U.S.

patients

Year of Establishment: 1876

▪

Over the past 20 years, Lilly Cares has helped more than one million patients with financial need receive medicines donated by Lilly

Headquarter: Indiana, US

Revenue: $28.3 Bn (2021)

Website: www.lilly.com

36

A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis 8. Healthcare Policy and Regulatory Landscape

8.1 Regulatory framework of global patient support program market

▪ Many countries, regions, and industry groups have local regulations that directly address (and often restrict) these programs. For example, Canada, the UK and Australia have industry codes specifically addressing PSPs and, in some cases, patient safety and data requirements or interactions with healthcare professionals (HCPs) and patients in connection with PSPs

▪ Reimbursement of patient support program is done by various ways like bridging drugs (temporary or limited supply of drug directly to a patient, provider, or institution), financial assistance (Payment on part of the drug cost; Payment may be based on applicant’s; income and family size; Payment may be given to someone with or without coverage in place) and compassionate drugs (temporary or long-term supply of drug to person in unique clinical situation) 38

A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis 9. Future Development Growth

9.1 Recent developments in patient support program

▪

AI, machine learning and natural language processing tools can identify both clinical and socioeconomic data points to ensure patient support teams are spending time with the right patients, particularly with those who may be closer to non-adherence

▪

Pharma manufacturers often use training materials to create awareness for these programs, a channel growing in popularity is actively participating in the patient journey — more specifically, connectivity with electronic health records (EHRs) systems to augment education. These integrations builds improved awareness for providers, growing program adoption

40

A Sample Report on Global Patient Support Program Market I Confidential

Global Patient Support Program Market Analysis 10. Conclusion

Strategic Recommendations

Growing Technology

Advancements

With the emerging

technology and the

transformation from…..

Emerging Initiative

Support for the HCPs

Ease in regulations by the

Patient support programs are

government and

collaborations between…..

also assisting HCPs to

deliver…..

3

2

4

Strong Demand

Advancement in healthcare

With the implementation of

delivery

government norms

towards…..

PSPs would enhance the

way healthcare was delivered

1

5

to the patient earlier, with…..

42

A Sample Report on Global Patient Support Program Market I Confidential

Methodology & Scope

Research methodology

▪

Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions

▪

We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources

▪

For forecasting, the following parameters are considered:

❑

Market drivers and restraints along with their current and expected impacts

❑

Technological scenario and expected developments

❑

End use industry trends and dynamics

❑

Trends in the consumer behavior

❑

Regulatory scenario and expected developments

❑

Current capacity and expected capacity additions up to 2030

▪

In our report we have assigned weights to the US specific parameters and quantified the market impacts. Which similarly, could be useful in identifying the global scenario

▪

We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions

▪

All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)

▪

The currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion 44

A Sample Report on Global Patient Support Program Market I Confidential

Analysis methodology

Our Analysis Methodology involves three critical stages: Market Data Analysis

Interpretation and

Data Collection

& Statistical Model

Presentation

Analysis &

Market Trends

Interpretation

Secondary

Research

Market Sizing &

Insights

Analysis

Primary

Research

Data Triangulation &

Presentation &

Validation

Reporting

45

A Sample Report on Global Patient Support Program Market I Confidential

Data triangulation and data validation

Top Down Approach

Final

Final Market size break up to

Market

rest of segmentation

Size

Validation from

Arriving at market size

Primary Interview

of each segment

Summarization of revenue

generated from companies

Validation from

to arrive at total market size

Primary Interview

Revenue generated by products &

Final

services offered by companies

Summary

Bottom Up Approach

46

A Sample Report on Global Patient Support Program Market I Confidential

Key benefits for stakeholders from this report The study provides an in-depth analysis of the Global Patient Support Program market with current trends and future estimations to elucidate the imminent investment pockets Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables

Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities

Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors 47

A Sample Report on Global Patient Support Program Market I Confidential

Time Frame

Report Attribute

Details

Quantitative Units

Revenue in USD Million/Billion (Mn/Bn)

Base Year for

2021

Estimation

Market Overview, Revenue Forecast, Market

Segmentation, Growth Factors and Trends,

Report Coverage

Company Profiles, Competitive Landscape,

Regulatory Landscape, Future Opportunities

Report Customization (5 working days) with

purchase. We will provide you with data that is Customized Report

currently not a part of our scope as a part of 2022-Forecast

customization

2030

Period

Pricing and purchase

Avail customized purchase options to meet

options

your exact research needs

What kind of Data is Presented

in this Report?

This report presents data, which is:

Reliable

Expert-verified

Real

Comprehensive

Easy to read

The report is prepared

The data is prepared by

Allowing you to

Covers everything you

You do not have to be a

using a proven

a team of highly qualified

confidently make

would need to know

market expert to

methodology and

& experienced research

smarter business

about the market

understand what really is

insightful research

analysts & vetted by our

and strategic

including market size,

happening on the market

local associates

decisions

competitive analysis &

and how it works

much more

www.insights10.com

About

Lifesciences Market

Research Reports you

can trust

A large database of over 30,000 syndicated market research reports in pharmaceuticals and

healthcare sector at global, regional as well as country level. We also provide customized

research reports tailor made to suit your needs

www.insights10.com

Get Insights to take

informed Business

Decisions

Insights10 is a healthcare focused market

research firm founded with an aim of being an insights driven company in the data driven world and delivering actionable insights that can drive decision and strategy making process for

businesses

www.insights10.com

Market Research Reports

across various domains of healthcare

Pharmaceuticals

Digital

Medical

Healthcare

OTC &

Clinical

(Diseases & Drugs) Health

Devices

Services

Nutraceuticals

Trials

Market Research Reports

1

6

Full-Time Engagement

Customized Reports

2

7

Conference Coverage

Our

Primary Research

3

Services

8

Competitive Intelligence

Strategic Research Projects

4

9

Regulatory Compliance

Database Services

5

10

Report Subscription Services

Our Research Process

01

02

03

04

05

Identification of

Market

Collection of

Collaboration

Verification &

Data

Dynamics

Data

of Data

Analysis

www.insights10.com

Statistical Databases

Company Websites/Annual Reports

Data

Sources

Trade Publications

We have access to multiple highly

Online Databases

reliable free and subscription data

sources. We have many years of

experience to understand which

Published Research Reports

sources are more dependable for what

and which to prefer for the reliable and

Whitepapers

latest information.

Press Releases of Key Market Players

www.insights10.com

Over the years, we have developed an in-depth experience of executing market analysis at global, regional & country specific level in life sciences.

Our team has

conducted market

research across 62+

global markets in

America, Europe,

Middle East, Africa and

Asia Pacific regions

Research Projects Done

Project Leadership Team

Dr. Purav Gandhi

Mukesh Nayak

Ritu Baliya

Dhruv Joshi

Founder & CEO

Head - Marketing

Engagement Manager

Consultant

Purav is a physician and an

Mukesh is an engineering graduate

Ritu has over 6 years of experience in

Dhruv Joshi is an engineer and has done

entrepreneur with 12+ years of

with an MBA in Marketing. He is a

strategy building, market assessments,

Masters in Hospital Administration with

experience in Healthcare & Life

seasoned healthcare market

market sizing, and RWE for global MNC

over 4 years of experience in the

Sciences industry spanning across

research & marketing professional

healthcare & biopharma clients across

healthcare and life science industry. He

strategy, market access, health

with a progressive experience of over

diff. markets (America, Europe, Africa,

has gained proficiency in market

informatics and RWE, digital health,

20 years in Life Sciences, Pharma

APAC and Middle East). Her areas of

research, market assessment, and

analytics and data science. Purav

and Medical Device sectors . With an

expertise include: Indentifying emerging

developing insights from it. He has

studied medicine from Gujarat

in-depth understanding of primary

trends in life sciences industry,

worked on various consulting projects

University and also completed his MBA

research, he has conducted

Competitor landscape assessment,

across different geographies including

from IIM-Kozhikode. Purav started his

hundreds of interviews of various

Disease opportunity assessments etc.

Asia, Europe, US, MENA. He has been

career with Deloitte working on strategy

stakeholders in pharma & healthcare

She is a pro in secondary and primary

aligned in working for sector reports of

consulting engagements and also co-

& completed several research

research with a deep domain expertise

various geographies along with market

founded ConvergeHealth by Deloitte.

projects across life sciences industry.

in healthcare sector.

sizing and forecasting.

7 years of experience working with leading organizations in pharma, MedTech and healthcare domain. Some of our recent clients are mentioned below

… and many more

We would be happy to help.

Web: www.insights10.com

Email: insights@insights10.com

Call: (+91) 931 639 7935

Whatsapp: (+91) 931 639 7935